Vienna, Austria

ESTRO 2025

Session

Sunday
May 04
17:00 - 18:00
Business 3-4
Upper GI 3
Agnieszka Namysł-Kaletka, Poland;
Marcel Verheij, The Netherlands
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will be recorded and made available via the online platfrom and mobile app.
Poster Discussions
Clinical
GI
17:00 - 17:06
CBCT-based online adaptive radiotherapy of esophageal cancer in the neoadjuvant setting: dosimetric analysis, toxicity and treatment response
Nicolas Bachmann, Switzerland
E25-2149
17:06 - 17:12
Is surgery in esophageal cancer patients with complete response after neo-adjuvant chemoradiotherapy necessary?
Efrat Gur, Israel
E25-4533
17:18 - 17:24
Defining the dose-volume constraints for the UK PROTIEUS oesophagus trial – ensuring a fair comparison between photons and protons
Geraint Lewis, United Kingdom
E25-1085
17:24 - 17:30
Neoadjuvant chemoradiotherapy in operable gastric cancer: 20-year results of the phase II trial.
Małgorzata Wydmańska, Poland
E25-4592
17:30 - 17:36
Outcome of magnetic resonance guided stereotactic body radiotherapy for hepatocellular carcinoma - an R-IDEAL stage IIb trial
Simon Boeke, Germany
E25-2191
17:36 - 17:42
Depth of Response and Duration of Response are Predictive of Survival for Hepatocellular Carcinoma treated with SBRT and Immunotherapy
Chi Leung Chiang, China, Hong Kong Special Administrative Region
E25-4632
17:48 - 17:54
Nanoray Pancreas: A Phase I Study of NBTXR3 activated by Radiotherapy for Locally Advanced or Borderline Resectable Pancreatic Cancer (LAPC or BRPC)
Eugene Koay, USA
E25-2265
17:54 - 18:00
Improved PTV coverage and OAR sparing with online adaptive MR-guided radiotherapy in pancreatic cancer
Paul Rogowski, Germany
E25-3454